IHC staining validated the much lower expression of KI‐67, Fibronectin, GPX4, and Nrf2 in tumor samples from the OXA/sh‐FOXA2 group of mice, which was comparable with the OXA and sh‐FOXA2 single treatment groups (Figure S5D, Supporting Information). This evidence concerns the gene GPX4 and neoplasm.